Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Butterfly Network, Inc. f/k/a Longview Acquisition Corp., of Class Action Lawsuit and Upcoming Deadline – BFLY
Cumberland County Man Pleads Guilty To Health Care Fraud, Money Laundering, And Theft Of Public Money
New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy
